BriaCell Therapeutics Overview

BriaCell Therapeutics Operating Income

Operating Income for BCTX.

Quarterly Operating Income

$-7684881.00

↑ 21.44% YoY

As of Apr 30, 2026

Annual Operating Income (TTM)

$500617.00

↓ 102.05% YoY

Trailing 12 months ending Apr 30, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin